SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aventus Network

Aventus Network (AVT) is experiencing heightened community interest, largely fueled by recent announcements including the incorporation of its DAO in the UAE and the strategic appointment of Dr. Marwan Al Zarouni to deepen its presence in the region. The community is actively discussing the potential for a significant breakout, emphasizing AVT's low market capitalization, robust Polkadot integration, and the expanding utility driven by its enterprise-focused Aventus Cloud offerings.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending due to the highly anticipated and successful orbital launch of its BlueBird 6 satellite, a pivotal step in the direct-to-device cellular broadband race. This milestone, which significantly enhances network capabilities, has fueled strong bullish sentiment among investors eager for future expansion, though some remain watchful of the long-term path to profitability amid current valuations.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is experiencing heightened trading activity and intense community discussion, largely fueled by the release of Epstein-related documents and the resulting allegations against Donald Trump. While many investors are expressing strong bearish sentiment citing these claims, others are dismissing the controversy as political noise and highlighting the company's recent merger for its future potential.

TOSHI

TOSHI is drawing significant attention following its recent Coinone KRW listing and ongoing discussions about its evolving utility, including future mobile service development within the Base ecosystem. Despite recent price weakness and some community frustration, many dedicated holders remain strongly bullish, viewing current levels as a prime accumulation opportunity ahead of anticipated major rallies. As the 'Face of Base,' TOSHI's robust community and potential for further exchange listings continue to fuel conversation.

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Dynavax Technologies Corp.

Dynavax Technologies is trending following its recent exclusive licensing agreement for Vaxart's novel oral COVID-19 vaccine program and the authorization of a new $100 million share repurchase program. Investors are actively discussing the potential of this oral vaccine platform to transform the market, especially with promising early Phase 1/2 data for its shingles candidate, Z-1018, showing strong immune responses and better tolerability compared to an existing vaccine. While many see these as significant growth catalysts, community discussions also highlight a history of management performance concerns and the ongoing proxy fight initiated by Deep Track Capital.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

AVNT is a trending cryptocurrency, heavily discussed for its integration with the Coinbase #Base app as a perpetual decentralized exchange aiming to rival major platforms. Community sentiment is sharply divided, with enthusiastic supporters anticipating significant growth due to its low market cap and strong backing, while critics decry it as a 'scam' or 'rug pull' citing recent price declines and perceived tokenomics issues.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. is trending due to the Pipeline Hazardous Materials Safety Administration (PHMSA) granting approval for the Las Flores Pipeline restart, effectively shifting regulatory authority from California to federal oversight. This is seen by the community as a "game-changing" catalyst, de-risking the company's offshore oil assets and igniting speculation of a significant short squeeze and revaluation.

Avient Corp. engages in the business of thermoplastic compounds. It operates through the Color, Additives, and Inks and Specialty Engineered Materials segments. The Color, Additives, and Inks segment provides custom color and additive concentrates in solid and liquid form for thermoplastics, dispersions for thermosets, specialty inks, plasticols, and vinyl slush molding solutions. The Specialty Engineered Materials segment makes polymer formulations, services, and solutions for designers, assemblers, and processors of thermoplastic materials. The company was founded on August 31, 2000 and is headquartered in Avon Lake, OH.

Avient Corp

Avient (AVNT) is trending as the market reacts positively to recent strong financial performance and multiple analyst upgrades, underscoring the company's strategic shift toward organic growth in specialty materials. The community is actively discussing bullish technical signals, including significant volume and a 'coiled spring' pattern, with many anticipating further upside. This renewed interest is fueled by Avient's focus on innovative and sustainable solutions, positioning it favorably in evolving markets.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending on news of its upcoming inclusion in the S&P MidCap 400 index, driving significant community discussion around potential institutional buying and enhanced visibility. This development, coupled with its recent strong earnings report, first GAAP profit, and leadership in Agentic AI, fuels widespread bullish sentiment, with many anticipating substantial long-term growth and a potential short squeeze.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending after recently pausing its aggressive Bitcoin accumulation, instead raising significant cash reserves through share sales. This strategic shift has ignited intense community debate, with many questioning shareholder dilution and the stock's pronounced underperformance relative to Bitcoin, despite trading at a discount to its vast crypto holdings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kura Oncology (NASDAQ:KURA) Shares Gap Up - Here's Why

Kura Oncology (NASDAQ:KURA) Shares Gap Up - Should You Buy...

Kura Oncology, Inc. $KURA Stock Position Lifted by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. grew its position in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 37.6% in the third quarter, according to its most recent 13F filing with the Securities and...

Francis Burrows Sells 23,726 Shares of Kura Oncology (NASDAQ:KURA) Stock

Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) insider Francis Burrows sold 23,726 shares of the firm's stock in a transaction on Thursday, December 18th. The shares were sold at an average...

Lightning Round: Don't get involved in any 'year of magical investing' stock: Jim Cramer

'Mad Money' host Jim Cramer weighs in on stocks including: SentinelOne, Kura Oncology, Bitmine Immersion Technology, Ciena, and Credo Technology...

Kura Oncology, Inc. (NASDAQ:KURA) Given Consensus Rating of "Moderate Buy" by Brokerages

Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) has been given a consensus rating of "Moderate Buy" by the thirteen research firms that are currently covering the firm, Marketbeat.com reports...

EcoR1 Capital LLC Boosts Stock Position in Kura Oncology, Inc. $KURA

EcoR1 Capital LLC increased its stake in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 59.1% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The...

Kura Oncology, Inc. $KURA Shares Sold by Armistice Capital LLC

Armistice Capital LLC trimmed its holdings in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 5.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC...

Kura Oncology (NASDAQ:KURA) Shares Down 4.6% - What's Next?

Kura Oncology (NASDAQ:KURA) Trading Down 4.6% - Here's What Happened...

Kura Oncology, Inc. $KURA Shares Sold by Walleye Capital LLC

Walleye Capital LLC reduced its holdings in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 17.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange...

Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points

Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points PR Newswire VANCOUVER, BC, Dec...

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.25	--	--	N/A
Q3 '25	-$0.73	-$0.85	-16.44%	MISSED
Q2 '25	-$0.41	-$0.75	-83.31%	MISSED
Q1 '25	-$0.60	-$0.66	-10.01%	MISSED
Q4 '24	-$0.64	-$0.22	65.39%	BEAT

KURA
Kura Oncology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest KURA News

KURAKura Oncology Inc